Global oncology R&D continues to expand, bringing exciting new treatment options to patients. Seventy percent of the R&D pipeline is driven by the innovation of biotech companies. This creates immense pressure to deliver novel treatments and secure investor funding in a highly complex environment.

Join the on-demand webinar to hear from experts with the IQVIA Institute and IQVIA Biotech about global oncology trends impacting sponsors and how to optimize clinical trial strategy.

Speakers:

Murray Aitken
Executive Director, IQVIA Institute for Human Data Science

Gerhard du Toit
Global Oncology Head, IQVIA Biotech